Increased plasma levels of intermedin and brain natriuretic peptide associated with severity of coronary stenosis in acute coronary syndrome

Peptides

Volumn 42, Issue , 2013, Pages 84-88

  Qin, Yan Wen ^a   Teng, Xu ^b,d   He, Ji Qiang ^a   Du, Jie ^a   Tang, Chao Shu ^a   Qi, Yong Fen ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d Hebei Key Laboratory of Laboratory Animal Science   (China)

Author keywords

Acute coronary syndrome; Brain natriuretic peptide; Intermedin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INTERMEDIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ACUTE CORONARY SYNDROME; ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE HORMONES;

MUS; RATTUS;

EID: 84874546106     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.01.011     Document Type: Article

References (45)

1. P. Alberto, I. Francesca, S. Chiara, and N. Ranuccio Acute coronary syndromes: from the laboratory markers to the coronary vessels Biomark Insights 1 2007 123 130
2. D. Bell, and B.J. McDermott Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems Br J Pharmacol 153 SUPPL. 1 2008 S247 S262
3. D. Bell, Y. Zhao, F.P. McCoy, A. Devine, and B.J. McDermott Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes Cell Physiol Biochem 21 2008 409 420
4. D. Bell, Y.Y. Zhao, A.B. Devine, and B.J. McDermott Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components Cell Physiol Biochem 21 2008 203 214
5. S. Blankenberg, T. Zeller, O. Saarela, A.S. Havulinna, F. Kee, and H. Tunstall-Pedoe Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
6. E. Braunwald Unstable angina: an etiologic approach to management Circulation 98 1998 2219 2222
7. B. Cam-Etoz, N. Isbil-Buyukcoskun, and K. Ozluk Cardiovascular effects of the intracerebroventricular injection of adrenomedullin: roles of the peripheral vasopressin and central cholinergic systems Braz J Med Biol Res 45 2012 250 255
8. L.R. Castro, M.C. Alencar, M.M. Barbosa, C. Nunes Mdo, J.R. Cardoso, and A.L. Ribeiro NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome Arq Bras Cardiol 97 2011 456 461
9. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, and C.H. McCabe The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
10. X. Du, Y. Cao, P. Xue, Z. Lin, Z. Zeng, and Q. Xia Protective effect of intermedin on myocardial cell in a rat model of severe acute pancreatitis Cell Mol Biol Lett 16 2011 462 476
11. K.M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome J Am Coll Cardiol 54 2009 357 364
12. Y.S. Gong, X.F. Fan, X.M. Wu, L.G. Hu, C.S. Tang, and Y.Z. Pang Changes of intermedin/adrenomedullin 2 and its receptors in the right ventricle of rats with chronic hypoxic pulmonary hypertension Sheng Li Xue Bao 59 2007 210 214
13. E. Grossini, C. Molinari, D.A. Mary, F. Uberti, P.P. Caimmi, and G. Vacca Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release J Appl Physiol 107 2009 1037 1050
14. T. Hirose, K. Totsune, N. Mori, R. Morimoto, M. Hashimoto, and Y. Nakashige Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure Eur J Heart Fail 10 2008 840 849
15. Y. Hong, D.L. Hay, R. Quirion, and D.R. Poyner The pharmacology of adrenomedullin 2/intermedin Br J Pharmacol 166 2012 110 120
16. Y.X. Jia, J.H. Yang, C.S. Pan, B. Geng, J. Zhang, and Y. Xiao Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats Eur J Pharmacol 549 2006 117 123
17. K. Kikuta, H. Yasue, M. Yoshimura, E. Morita, H. Sumida, and H. Kato Increased plasma levels of B-type natriuretic peptide in patients with unstable angina Am Heart J 132 1996 101 107
18. Y. Liu, X. Li, D. Peng, Z. Tan, H. Liu, and Y. Qing Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease Am J Cardiol 103 2009 476 481
19. D.A. Morrow, and E. Braunwald Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy Circulation 108 2003 250 252
20. D.A. Morrow, J.A. de Lemos, M.S. Sabatine, S.A. Murphy, L.A. Demopoulos, and P.M. DiBattiste Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264 1272
21. C.M. Nagesh, and A. Roy Role of biomarkers in risk stratification of acute coronary syndrome Indian J Med Res 132 2010 627 633
22. G. Ndrepepa, S. Braun, J. Mehilli, N. von Beckerath, S. Nekolla, and W. Vogt N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis Am J Cardiol 97 2006 1151 1156
23. H. Nishida, T. Horio, Y. Suzuki, Y. Iwashima, K. Kamide, and K. Kangawa Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin Peptides 29 2008 599 605
24. T. Omland, A. Persson, L. Ng, R. O'Brien, T. Karlsson, and J. Herlitz N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
25. I. Ramasamy Biochemical markers in acute coronary syndrome Clin Chim Acta 412 2011 1279 1296
26. A.M. Richards, M.G. Nicholls, E.A. Espiner, J.G. Lainchbury, R.W. Troughton, and J. Elliott B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
27. J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y. Hsu Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes J Biol Chem 279 2004 7264 7274
28. S. Sadanandan, C.P. Cannon, K. Chekuri, S.A. Murphy, P.M. Dibattiste, and D.A. Morrow Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 564 568
29. J.Q. Song, X. Teng, Y. Cai, C.S. Tang, and Y.F. Qi Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion Apoptosis 14 2009 1061 1069
30. D. Staub, C. Nusbaumer, M.J. Zellweger, N. Jonas, D. Wild, and M.E. Pfisterer Use of B-type natriuretic peptide in the detection of myocardial ischemia Am Heart J 151 2006 1223 1230
31. Y. Takei, K. Inoue, M. Ogoshi, T. Kawahara, H. Bannai, and S. Miyano Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator FEBS Lett 556 2004 53 58
32. X. Teng, J. Song, G. Zhang, Y. Cai, F. Yuan, and J. Du Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway J Mol Med (Berl) 89 2011 1195 1205
33. R.S. Vasan Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2006 2335 2362
34. S. Wiese, T. Breyer, A. Dragu, R. Wakili, T. Burkard, and S. Schmidt-Schweda Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length Circulation 102 2000 3074 3079
35. P.S. Wild, R.B. Schnabel, E. Lubos, T. Zeller, C.R. Sinning, and T. Keller Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study Clin Chem 58 2012 226 236
36. R.S. Wright, J.L. Anderson, C.D. Adams, C.R. Bridges, D.E. Casey Jr., and S.M. Ettinger ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 2022 2060
37. J.H. Yang, Y. Cai, X.H. Duan, C.G. Ma, X. Wang, and C.S. Tang Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II Regul Pept 158 2009 19 25
38. J.H. Yang, Y.X. Jia, C.S. Pan, J. Zhao, M. Ouyang, and J. Yang Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts Biochem Biophys Res Commun 327 2005 713 719
39. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, and M. Jougasaki Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
40. M. Yoshimura, H. Yasue, K. Okumura, H. Ogawa, M. Jougasaki, and M. Mukoyama Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 1993 464 469
41. Y. Yuan, X. Wang, Q. Zeng, H.M. Wu, Y.F. Qi, and C.S. Tang Effects of continuous intermedin infusion on blood pressure and hemodynamic function in spontaneously hypertensive rats J Geriatr Cardiol 9 2012 17 27
42. Q. Zeng, Y. Yuan, X. Wang, H.M. Wu, L. Fan, and Y.F. Qi Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats Peptides 30 2009 391 399
43. X. Zeng, L. Li, and Q. Su The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis Clin Chem Lab Med 50 2012 731 739
44. H.Y. Zhang, W. Jiang, J.Y. Liu, Y. Li, C.L. Chen, and H.B. Xin Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model Hypertens Res 32 2009 861 868
45. L. Zhao, D.Q. Peng, J. Zhang, J.Q. Song, X. Teng, and Y.R. Yu Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion Peptides 33 2012 329 335